The goal of this Study is to provide prospective evidence of the frequency of skin discoloration in patients who have received the Magtrace® tracer for sentinel lymph node biopsy (SLNB) and to evaluate the impact that skin discoloration has on patients when it does occur, by using patient reported outcome measures such as questionnaires.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Kristalyn Gallagher
LCCC - Clinical Trials
Clinical or Medical
Observational
Cancer (Breast)
25-0545
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
